JW Lifescience Corporation

KRX:234080.KS

12390 (KRW) • At close July 7, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) KRW.

20242023202220212020201920182017201620152014201320122011
Operating Activities:
Net Income 43,987.53128,143.96614,961.26712,913.61917,300.05221,938.43915,820.96416,782.71415,161.60912,864.2139,356.5711,632.6193,467.9472,658.535
Depreciation & Amortization 15,737.14415,530.70314,956.09113,244.75312,246.48211,626.44811,098.39311,121.57513,172.27612,620.27512,006.28811,534.97511,190.62411,212.32
Deferred Income Tax 00000000000000
Stock Based Compensation 00000000000000
Change In Working Capital 2,963.698-1,284.514-22,380.857-3,657.899-1,593.47-13,125.2337,275.467-8,062.211-14,773.062-2,744.285-10,942.719-4,610.761,771.384-2,222.818
Accounts Receivables 17,157.927-1,835.121-21,950.6572,479.234-863.399-3,660.72711,909.647-9,279.423-12,395.68300000
Inventory -5,834.244-1,285.404-1,056.756-4,516.67-999.725-1,144.609-2,493.1241,690.3941,007.016-2,537.474-1,377.754-1,551.024594.4251,077.627
Accounts Payables 03,539.6712,729.584-2,072.5084,859.145-340.875-180.9771,765.9453,451.21200000
Other Working Capital -8,359.985-1,703.66-2,103.028452.045-4,589.491-7,979.0229,768.591-9,752.605-15,780.078-206.811-9,564.965-3,059.7361,176.959-3,300.445
Other Non Cash Items -11,998.581-4,815.9076,592.2497,664.57218,801.6363,835.911,935.0992,207.9232,520.333,156.5763,424.5932,238.6181,124.4973,117.018
Operating Cash Flow 50,689.79237,574.24814,128.75130,165.04646,754.724,275.56436,129.92322,050.00116,081.15325,896.77913,844.73310,795.45217,554.45214,765.055
Investing Activities:
Investments In Property Plant And Equipment -10,306.665-8,153.142-8,293.469-19,396.154-16,238.108-8,356.321-10,560.151-8,847.346-13,368.56-23,420.385-8,388.239-4,067.842-4,114.12-4,090.495
Acquisitions Net -49,437.04222-121.709-19,700-1009.39.922866.887000-488.007
Purchases Of Investments -17,003.782-21,202.03-38,381.202-655.908-1,700-100-80-180-190.325-70.189000
Sales Maturities Of Investments 23,520.16938,215.97913,637.7339,399.907-297.76110104.48010.32510.1890000
Other Investing Activites -14,806.624-846.2964,801.741-12,154.937374.87-4.967173.232-100.4362,246.139-1,922.427-2,832.958-174.58396.087611.574
Investing Cash Flow -68,033.9458,036.512-28,247.198-22,805.383-37,561-8,371.288-10,386.92-9,027.782-11,282.173-24,656.06-11,291.386-4,242.424-4,018.033-3,966.928
Financing Activities:
Debt Repayment 9,664-21,268.2621,198.83-2,713.294-8,140.74-10,559.8-5,349.8-8,355.8371,121.0375,666.717-1,845.345-2,667.706-10,199.231-10,798.551
Common Stock Issued 00000000000000
Common Stock Repurchased 000-6,748.5240000000000
Dividends Paid -7,742.277-7,742.277-7,742.277-7,917.277-7,917.277-7,917.277-7,917.277-4,750.366-6,400-6,106.986-738.726000
Other Financing Activities -145.253-297.775-341.41312,350-404.56-342.46500000-3,820.094-3,341.896-0
Financing Cash Flow 1,776.47-29,308.31213,115.14-5,029.095-16,462.577-18,819.542-13,267.077-13,106.203-5,278.963-440.269-2,584.071-6,487.8-13,541.127-10,798.551
Other Information:
Effect Of Forex Changes On Cash 00000-000-000-000
Net Change In Cash -12,710.59316,302.449-1,003.3062,330.568-7,268.876-2,915.26612,475.926-83.984-479.984800.45-30.72465.228-4.708-0.423
Cash At End Of Period 7,511.48220,222.0753,919.6264,922.9332,592.3659,861.24112,776.507300.581384.565864.54964.09994.82429.59627.708